Sristi Agrawal

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Idiopathic Pulmonary Fibrosis

Top Venues

Therapeutic delivery

Chemistry & biodiversity

Journal of mass spectrometry : JMS

Health care science

This page only lists publications with an associated author ORCID identifier.

Publications

Amol Chhatrapati Bisen, Ayush Dubey, Sristi Agrawal, Arpon Biswas, Kundan Singh Rawat, Saurabh Srivastava, Rabi Sankar Bhatta
Recent updates on ocular disease management with ophthalmic ointments. Therapeutic delivery 15 (6) (2024)
Amol Chhatrapati Bisen, Ayush Dubey, Sristi Agrawal, Arpon Biswas, Kundan Singh Rawat, Saurabh Srivastava, Rabi Sankar Bhatta
Recent updates on ocular disease management with ophthalmic ointments. Therapeutic delivery 15 (6) (2024)
Amol Chhatrapati Bisen, Anjali Mishra, Sristi Agrawal, Sachin Nashik Sanap, Arpon Biswas, Sarvesh Kumar Verma, Rabi Sankar Bhatta
Codetermination of antimicrobial agents in rabbit tear fluid using LC-MS/MS assay: Insights into ocular pharmacokinetic study. Journal of mass spectrometry : JMS 59 (6) (2024)
Amol Chhatrapati Bisen, Anjali Mishra, Sristi Agrawal, Sachin Nashik Sanap, Arpon Biswas, Sarvesh Kumar Verma, Rabi Sankar Bhatta
Codetermination of antimicrobial agents in rabbit tear fluid using LC-MS/MS assay: Insights into ocular pharmacokinetic study. Journal of mass spectrometry : JMS 59 (6) (2024)
Amol Chhatrapati Bisen, Ayush Dubey, Sristi Agrawal, Arpon Biswas, Kundan Singh Rawat, Saurabh Srivastava, Rabi Sankar Bhatta
Recent updates on ocular disease management with ophthalmic ointments. Therapeutic delivery (2024)
Amol Chhatrapati Bisen, Sristi Agrawal, Ramakrishna Rayiti, Sachin Nashik Sanap, Arpon Biswas, Anjali Mishra, Neeraj Mohan Gupta, Rabi Sankar Bhatta
Pirfenidone: A Promising Drug in Ocular Therapeutics. Chemistry & biodiversity (2024)
Amol Chhatrapati Bisen, Sristi Agrawal, Ramakrishna Rayiti, Sachin Nashik Sanap, Arpon Biswas, Anjali Mishra, Neeraj Mohan Gupta, Rabi Sankar Bhatta
Pirfenidone: A Promising Drug in Ocular Therapeutics. Chemistry & biodiversity 21 (3) (2024)
Amol Chhatrapati Bisen, Sristi Agrawal, Ramakrishna Rayiti, Sachin Nashik Sanap, Arpon Biswas, Anjali Mishra, Neeraj Mohan Gupta, Rabi Sankar Bhatta
Pirfenidone: A Promising Drug in Ocular Therapeutics. Chemistry & biodiversity 21 (3) (2024)
Amol Chhatrapati Bisen, Ayush Dubey, Sristi Agrawal, Arpon Biswas, Kundan Singh Rawat, Saurabh Srivastava, Rabi Sankar Bhatta
Recent updates on ocular disease management with ophthalmic ointments. Therapeutic delivery 15 (6) (2024)
Amol Chhatrapati Bisen, Sristi Agrawal, Sachin Nashik Sanap, Heamanth Ganesan Ravi Kumar, Nelam Kumar, Rajdeep Gupta, Rabi Sankar Bhatta
COVID-19 retreats and world recovers: A silver lining in the dark cloud. Health care science 2 (4) (2023)
Sristi Agrawal, Sachin Nashik Sanap, Amol Chhatrapati Bisen, Arpon Biswas, Abhijit Deb Choudhury, Sarvesh Kumar Verma, Shubham Jaiswal, Tadigoppula Narender, Rabi Sankar Bhatta
Preclinical pharmacokinetics of 4-hydroxy isoleucine using LC-MS/MS: a potential polycystic ovary syndrome phytopharmaceutical therapeutics. Bioanalysis (2023)
Sachin Nashik Sanap, Amol Chhatrapati Bisen, Sristi Agrawal, Ashwini S Kedar, Rabi Sankar Bhatta
Ophthalmic nano-bioconjugates: critical challenges and technological advances. Therapeutic delivery (2023)
Amol Chhatrapati Bisen, Priyanka Rawat, Gaurav Sharma, Sachin Nashik Sanap, Sristi Agrawal, Shiv Kumar, Ashok Kumar, Abhijit Deb Choudhury, Sakshi Kamboj, Tadigoppula Narender, Sanjeev K Shukla, Sanjeev Kanojiya, Rabi Sankar Bhatta
Hesperidin: Enrichment, forced degradation, and structural elucidation of potential degradation products using spectral techniques. Rapid communications in mass spectrometry : RCM 37 (20) (2023)
Amol Chhatrapati Bisen, Sristi Agrawal, Sachin Nashik Sanap, Heamanth Ganesan Ravi Kumar, Nelam Kumar, Rajdeep Gupta, Rabi Sankar Bhatta
COVID-19 retreats and world recovers: A silver lining in the dark cloud. Health care science 2 (4) (2023)